Global Prostate-Specific Antigen (PSA) Test Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 78477
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Prostate-Specific Antigen (PSA) Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Prostate-Specific Antigen (PSA) Test size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Prostate-Specific Antigen (PSA) Test market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Prostate-Specific Antigen (PSA) Test market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

CLIA

ELISA

Other

Market segment by Application, can be divided into

Screening

Post-treatment Monitoring

Other

Market segment by players, this report covers

Abbott

Siemens Healthcare

DiaSorin

Roche

Beckman Coulter

PerkinElmer

Tosoh

Ortho Clinical

Fujirebio

Mediwatch (LABORIE)

BodiTech

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Prostate-Specific Antigen (PSA) Test product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Prostate-Specific Antigen (PSA) Test, with revenue, gross margin and global market share of Prostate-Specific Antigen (PSA) Test from 2019 to 2021.

Chapter 3, the Prostate-Specific Antigen (PSA) Test competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Prostate-Specific Antigen (PSA) Test market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Prostate-Specific Antigen (PSA) Test research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Prostate-Specific Antigen (PSA) Test

1.2 Classification of Prostate-Specific Antigen (PSA) Test by Type

1.2.1 Overview: Global Prostate-Specific Antigen (PSA) Test Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Type in 2020

1.2.3 CLIA

1.2.4 ELISA

1.2.5 Other

1.3 Global Prostate-Specific Antigen (PSA) Test Market by Application

1.3.1 Overview: Global Prostate-Specific Antigen (PSA) Test Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Screening

1.3.3 Post-treatment Monitoring

1.3.4 Other

1.4 Global Prostate-Specific Antigen (PSA) Test Market Size & Forecast

1.5 Global Prostate-Specific Antigen (PSA) Test Market Size and Forecast by Region

1.5.1 Global Prostate-Specific Antigen (PSA) Test Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Prostate-Specific Antigen (PSA) Test Market Size by Region, (2016-2021)

1.5.3 North America Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2016-2026)

1.5.4 Europe Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2016-2026)

1.5.6 South America Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Prostate-Specific Antigen (PSA) Test Market Drivers

1.6.2 Prostate-Specific Antigen (PSA) Test Market Restraints

1.6.3 Prostate-Specific Antigen (PSA) Test Trends Analysis

2 Company Profiles

2.1 Abbott

2.1.1 Abbott Details

2.1.2 Abbott Major Business

2.1.3 Abbott Prostate-Specific Antigen (PSA) Test Product and Solutions

2.1.4 Abbott Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Abbott Recent Developments and Future Plans

2.2 Siemens Healthcare

2.2.1 Siemens Healthcare Details

2.2.2 Siemens Healthcare Major Business

2.2.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Product and Solutions

2.2.4 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Siemens Healthcare Recent Developments and Future Plans

2.3 DiaSorin

2.3.1 DiaSorin Details

2.3.2 DiaSorin Major Business

2.3.3 DiaSorin Prostate-Specific Antigen (PSA) Test Product and Solutions

2.3.4 DiaSorin Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 DiaSorin Recent Developments and Future Plans

2.4 Roche

2.4.1 Roche Details

2.4.2 Roche Major Business

2.4.3 Roche Prostate-Specific Antigen (PSA) Test Product and Solutions

2.4.4 Roche Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Roche Recent Developments and Future Plans

2.5 Beckman Coulter

2.5.1 Beckman Coulter Details

2.5.2 Beckman Coulter Major Business

2.5.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Product and Solutions

2.5.4 Beckman Coulter Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Beckman Coulter Recent Developments and Future Plans

2.6 PerkinElmer

2.6.1 PerkinElmer Details

2.6.2 PerkinElmer Major Business

2.6.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Product and Solutions

2.6.4 PerkinElmer Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 PerkinElmer Recent Developments and Future Plans

2.7 Tosoh

2.7.1 Tosoh Details

2.7.2 Tosoh Major Business

2.7.3 Tosoh Prostate-Specific Antigen (PSA) Test Product and Solutions

2.7.4 Tosoh Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Tosoh Recent Developments and Future Plans

2.8 Ortho Clinical

2.8.1 Ortho Clinical Details

2.8.2 Ortho Clinical Major Business

2.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Product and Solutions

2.8.4 Ortho Clinical Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Ortho Clinical Recent Developments and Future Plans

2.9 Fujirebio

2.9.1 Fujirebio Details

2.9.2 Fujirebio Major Business

2.9.3 Fujirebio Prostate-Specific Antigen (PSA) Test Product and Solutions

2.9.4 Fujirebio Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Fujirebio Recent Developments and Future Plans

2.10 Mediwatch (LABORIE)

2.10.1 Mediwatch (LABORIE) Details

2.10.2 Mediwatch (LABORIE) Major Business

2.10.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Product and Solutions

2.10.4 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Mediwatch (LABORIE) Recent Developments and Future Plans

2.11 BodiTech

2.11.1 BodiTech Details

2.11.2 BodiTech Major Business

2.11.3 BodiTech Prostate-Specific Antigen (PSA) Test Product and Solutions

2.11.4 BodiTech Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 BodiTech Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Prostate-Specific Antigen (PSA) Test Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Prostate-Specific Antigen (PSA) Test Players Market Share

3.2.2 Top 10 Prostate-Specific Antigen (PSA) Test Players Market Share

3.2.3 Market Competition Trend

3.3 Prostate-Specific Antigen (PSA) Test Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Prostate-Specific Antigen (PSA) Test Revenue and Market Share by Type (2016-2021)

4.2 Global Prostate-Specific Antigen (PSA) Test Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Application (2016-2021)

5.2 Prostate-Specific Antigen (PSA) Test Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2026)

6.2 North America Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2026)

6.3 North America Prostate-Specific Antigen (PSA) Test Market Size by Country

6.3.1 North America Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2026)

6.3.2 United States Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

6.3.3 Canada Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

6.3.4 Mexico Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2026)

7.2 Europe Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2026)

7.3 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country

7.3.1 Europe Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2026)

7.3.2 Germany Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

7.3.3 France Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

7.3.5 Russia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

7.3.6 Italy Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2026)

8.2 Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2026)

8.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region

8.3.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Region (2016-2026)

8.3.2 China Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

8.3.3 Japan Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

8.3.4 South Korea Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

8.3.5 India Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

8.3.7 Australia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2026)

9.2 South America Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2026)

9.3 South America Prostate-Specific Antigen (PSA) Test Market Size by Country

9.3.1 South America Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2026)

9.3.2 Brazil Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

9.3.3 Argentina Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2026)

10.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2026)

10.3 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country

10.3.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2026)

10.3.2 Turkey Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

10.3.4 UAE Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Prostate-Specific Antigen (PSA) Test Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Prostate-Specific Antigen (PSA) Test Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Prostate-Specific Antigen (PSA) Test Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Prostate-Specific Antigen (PSA) Test Revenue (USD Million) by Region (2016-2021)

Table 5. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Region (2021-2026)

Table 6. Abbott Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Major Business

Table 8. Abbott Prostate-Specific Antigen (PSA) Test Product and Solutions

Table 9. Abbott Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Siemens Healthcare Corporate Information, Head Office, and Major Competitors

Table 11. Siemens Healthcare Major Business

Table 12. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Product and Solutions

Table 13. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. DiaSorin Corporate Information, Head Office, and Major Competitors

Table 15. DiaSorin Major Business

Table 16. DiaSorin Prostate-Specific Antigen (PSA) Test Product and Solutions

Table 17. DiaSorin Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Roche Corporate Information, Head Office, and Major Competitors

Table 19. Roche Major Business

Table 20. Roche Prostate-Specific Antigen (PSA) Test Product and Solutions

Table 21. Roche Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Beckman Coulter Corporate Information, Head Office, and Major Competitors

Table 23. Beckman Coulter Major Business

Table 24. Beckman Coulter Prostate-Specific Antigen (PSA) Test Product and Solutions

Table 25. Beckman Coulter Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. PerkinElmer Corporate Information, Head Office, and Major Competitors

Table 27. PerkinElmer Major Business

Table 28. PerkinElmer Prostate-Specific Antigen (PSA) Test Product and Solutions

Table 29. PerkinElmer Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Tosoh Corporate Information, Head Office, and Major Competitors

Table 31. Tosoh Major Business

Table 32. Tosoh Prostate-Specific Antigen (PSA) Test Product and Solutions

Table 33. Tosoh Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Ortho Clinical Corporate Information, Head Office, and Major Competitors

Table 35. Ortho Clinical Major Business

Table 36. Ortho Clinical Prostate-Specific Antigen (PSA) Test Product and Solutions

Table 37. Ortho Clinical Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Fujirebio Corporate Information, Head Office, and Major Competitors

Table 39. Fujirebio Major Business

Table 40. Fujirebio Prostate-Specific Antigen (PSA) Test Product and Solutions

Table 41. Fujirebio Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Mediwatch (LABORIE) Corporate Information, Head Office, and Major Competitors

Table 43. Mediwatch (LABORIE) Major Business

Table 44. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Product and Solutions

Table 45. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. BodiTech Corporate Information, Head Office, and Major Competitors

Table 47. BodiTech Major Business

Table 48. BodiTech Prostate-Specific Antigen (PSA) Test Product and Solutions

Table 49. BodiTech Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Global Prostate-Specific Antigen (PSA) Test Revenue (USD Million) by Players (2019-2021)

Table 51. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Players (2019-2021)

Table 52. Breakdown of Prostate-Specific Antigen (PSA) Test by Company Type (Tier 1, Tier 2 and Tier 3)

Table 53. Prostate-Specific Antigen (PSA) Test Players Head Office, Products and Services Provided

Table 54. Prostate-Specific Antigen (PSA) Test Mergers & Acquisitions in the Past Five Years

Table 55. Prostate-Specific Antigen (PSA) Test New Entrants and Expansion Plans

Table 56. Global Prostate-Specific Antigen (PSA) Test Revenue (USD Million) by Type (2016-2021)

Table 57. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Type (2016-2021)

Table 58. Global Prostate-Specific Antigen (PSA) Test Revenue Forecast by Type (2021-2026)

Table 59. Global Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2021)

Table 60. Global Prostate-Specific Antigen (PSA) Test Revenue Forecast by Application (2021-2026)

Table 61. North America Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2021) & (USD Million)

Table 62. North America Prostate-Specific Antigen (PSA) Test Revenue by Type (2021-2026) & (USD Million)

Table 63. North America Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2021) & (USD Million)

Table 64. North America Prostate-Specific Antigen (PSA) Test Revenue by Application (2021-2026) & (USD Million)

Table 65. North America Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2021) & (USD Million)

Table 66. North America Prostate-Specific Antigen (PSA) Test Revenue by Country (2021-2026) & (USD Million)

Table 67. Europe Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2021) & (USD Million)

Table 68. Europe Prostate-Specific Antigen (PSA) Test Revenue by Type (2021-2026) & (USD Million)

Table 69. Europe Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2021) & (USD Million)

Table 70. Europe Prostate-Specific Antigen (PSA) Test Revenue by Application (2021-2026) & (USD Million)

Table 71. Europe Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2021) & (USD Million)

Table 72. Europe Prostate-Specific Antigen (PSA) Test Revenue by Country (2021-2026) & (USD Million)

Table 73. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2021) & (USD Million)

Table 74. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Type (2021-2026) & (USD Million)

Table 75. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2021) & (USD Million)

Table 76. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Application (2021-2026) & (USD Million)

Table 77. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Region (2016-2021) & (USD Million)

Table 78. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Region (2021-2026) & (USD Million)

Table 79. South America Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2021) & (USD Million)

Table 80. South America Prostate-Specific Antigen (PSA) Test Revenue by Type (2021-2026) & (USD Million)

Table 81. South America Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2021) & (USD Million)

Table 82. South America Prostate-Specific Antigen (PSA) Test Revenue by Application (2021-2026) & (USD Million)

Table 83. South America Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2021) & (USD Million)

Table 84. South America Prostate-Specific Antigen (PSA) Test Revenue by Country (2021-2026) & (USD Million)

Table 85. Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2021) & (USD Million)

Table 86. Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Type (2021-2026) & (USD Million)

Table 87. Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2021) & (USD Million)

Table 88. Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Application (2021-2026) & (USD Million)

Table 89. Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2021) & (USD Million)

Table 90. Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Prostate-Specific Antigen (PSA) Test Picture

Figure 2. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Type in 2020

Figure 3. CLIA

Figure 4. ELISA

Figure 5. Other

Figure 6. Prostate-Specific Antigen (PSA) Test Revenue Market Share by Application in 2020

Figure 7. Screening Picture

Figure 8. Post-treatment Monitoring Picture

Figure 9. Other Picture

Figure 10. Global Prostate-Specific Antigen (PSA) Test Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 11. Global Prostate-Specific Antigen (PSA) Test Revenue and Forecast (2016-2026) & (USD Million)

Figure 12. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Region (2016-2026)

Figure 13. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Region in 2020

Figure 14. North America Prostate-Specific Antigen (PSA) Test Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Europe Prostate-Specific Antigen (PSA) Test Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. South America Prostate-Specific Antigen (PSA) Test Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Middle East and Africa Prostate-Specific Antigen (PSA) Test Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Prostate-Specific Antigen (PSA) Test Market Drivers

Figure 20. Prostate-Specific Antigen (PSA) Test Market Restraints

Figure 21. Prostate-Specific Antigen (PSA) Test Market Trends

Figure 22. Abbott Recent Developments and Future Plans

Figure 23. Siemens Healthcare Recent Developments and Future Plans

Figure 24. DiaSorin Recent Developments and Future Plans

Figure 25. Roche Recent Developments and Future Plans

Figure 26. Beckman Coulter Recent Developments and Future Plans

Figure 27. PerkinElmer Recent Developments and Future Plans

Figure 28. Tosoh Recent Developments and Future Plans

Figure 29. Ortho Clinical Recent Developments and Future Plans

Figure 30. Fujirebio Recent Developments and Future Plans

Figure 31. Mediwatch (LABORIE) Recent Developments and Future Plans

Figure 32. BodiTech Recent Developments and Future Plans

Figure 33. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Players in 2020

Figure 34. Prostate-Specific Antigen (PSA) Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 35. Global Top 3 Players Prostate-Specific Antigen (PSA) Test Revenue Market Share in 2020

Figure 36. Global Top 10 Players Prostate-Specific Antigen (PSA) Test Revenue Market Share in 2020

Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 38. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Type in 2020

Figure 39. Global Prostate-Specific Antigen (PSA) Test Market Share Forecast by Type (2021-2026)

Figure 40. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Application in 2020

Figure 41. Global Prostate-Specific Antigen (PSA) Test Market Share Forecast by Application (2021-2026)

Figure 42. North America Prostate-Specific Antigen (PSA) Test Sales Market Share by Type (2016-2026)

Figure 43. North America Prostate-Specific Antigen (PSA) Test Sales Market Share by Application (2016-2026)

Figure 44. North America Prostate-Specific Antigen (PSA) Test Revenue Market Share by Country (2016-2026)

Figure 45. United States Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. Canada Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Mexico Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Europe Prostate-Specific Antigen (PSA) Test Sales Market Share by Type (2016-2026)

Figure 49. Europe Prostate-Specific Antigen (PSA) Test Sales Market Share by Application (2016-2026)

Figure 50. Europe Prostate-Specific Antigen (PSA) Test Revenue Market Share by Country (2016-2026)

Figure 51. Germany Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. France Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. United Kingdom Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Russia Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Italy Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Asia-Pacific Prostate-Specific Antigen (PSA) Test Sales Market Share by Type (2016-2026)

Figure 57. Asia-Pacific Prostate-Specific Antigen (PSA) Test Sales Market Share by Application (2016-2026)

Figure 58. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue Market Share by Region (2016-2026)

Figure 59. China Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Japan Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. South Korea Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. India Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Southeast Asia Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Australia Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. South America Prostate-Specific Antigen (PSA) Test Sales Market Share by Type (2016-2026)

Figure 66. South America Prostate-Specific Antigen (PSA) Test Sales Market Share by Application (2016-2026)

Figure 67. South America Prostate-Specific Antigen (PSA) Test Revenue Market Share by Country (2016-2026)

Figure 68. Brazil Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Argentina Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Middle East and Africa Prostate-Specific Antigen (PSA) Test Sales Market Share by Type (2016-2026)

Figure 71. Middle East and Africa Prostate-Specific Antigen (PSA) Test Sales Market Share by Application (2016-2026)

Figure 72. Middle East and Africa Prostate-Specific Antigen (PSA) Test Revenue Market Share by Country (2016-2026)

Figure 73. Turkey Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Saudi Arabia Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. UAE Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Methodology

Figure 77. Research Process and Data Source